BDBM465790 4-(3-((1R,3S,4S)-2-acryloyl-2-azabicyclo[2.2.1]heptan-3-yl)-8-aminoimidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide::US10793576, Example 22

SMILES Nc1nccn2c(nc(-c3ccc(cc3)C(=O)Nc3ccccn3)c12)C1[C@H]2CC[C@H](C2)N1C(=O)C=C

InChI Key InChIKey=VSZPBQSEJAPADZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 465790   

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465790(US10793576, Example 22 | 4-(3-((1R,3S,4S)-2-acrylo...)
Affinity DataIC50: 3.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent